Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Monomax 1 Hr48

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Unknown1
Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Research Network

Common Treatments

  • Monomax 1 Hr481
  • Monomax 20 Hr261
  • Retrobulbar Block1
  • Pds 20 Vs Monomax 201
  • Ketamine1

Active Sponsors

  • Fundación Pública Andaluza para la gestión de la Investigación en Sevilla1
  • Hospital San Juan de Dios Tenerife1
  • Nazmy Edward Seif1

Top Investigators

Related Conditions

  • Eventration1
  • Pain Postoperative1
  • Suture Complications Mechanical1
  • Linea Alba Hernia1
  • Abdominal Wall Defect1

Activity Timeline